Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder

JAMA Psychiatry(2022)10.1001/jamapsychiatry.2022.4020Source: DataRank Database

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder is a research paper published in JAMA Psychiatry (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.18)OA: greenTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Bethea A. Kleykamp ORCID,Sandra D. Comer ORCID,Roland R. Griffiths ORCID,Andrew S. Huhn ORCID,Matthew W. Johnson ORCID

Live enrichment

PubMed:36449315 PMC:PMC10297827 OpenAlex:https://openalex.org/W4310422008

NIDA NIH HHS

Grant: UH3 DA048386

NIDA NIH HHS

Grant: UH3 DA047711

NIDA NIH HHS

Grant: U01 DA051639

FDA HHS

Grant: U01 FD005936

NIDA NIH HHS

Grant: UG3 DA048386

NIAAA NIH HHS

Grant: K02 AA027300

NIDA NIH HHS

Grant: UG3 DA047711

National Institutes of Health

Grant: 5U01FD005936-02

Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Public-Private Partnership

FWCI

3.18

Citation Percentile

0.9%

Influential Citations

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10297827/pdf/nihms-1907289.pdf

publisherhttps://jamanetwork.com/journals/jamapsychiatry/articlepdf/2799201/jamapsychiatry_kiluk_2022_rv_220004_1671567505.76247.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10297827

journalhttps://doi.org/10.1001/jamapsychiatry.2022.4020

Fields of Study

Psychedelics and Drug StudiesOpioid Use Disorder TreatmentForensic Toxicology and Drug AnalysisMedicine03 medical and health sciences0302 clinical medicine0305 other medical scienceHumansAnalgesics, OpioidOpiate Substitution TreatmentQuality of LifeClinical Trials as TopicOpioid-Related DisordersBuprenorphine

MeSH Terms

Analgesics, OpioidBuprenorphineClinical Trials as TopicHumansOpioid-Related DisordersQuality of LifeOpiate Substitution Treatment

Keywords

Opioid use disorderMedicineAbstinenceAddictionPsychiatryIntensive care medicineClinical trialOpioidInternal medicineAnalgesics, OpioidClinical Trials as TopicOpiate Substitution TreatmentQuality of LifeHumansOpioid-Related DisordersBuprenorphine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder

FAIR Checklist

Authors (27)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)